alexa Recent Advancements In The Mass Spectrometry-based Analysis Of Protein Acetylation Changes Upon Boron Treatment
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Proteomics & Bioinformatics
August 04-06, 2014 Hilton-Chicago/Northbrook, Chicago, USA

Huseyin Cimen, Eray Esendir and Berna Ustuner
ScientificTracks Abstracts: J Proteomics Bioinform
DOI: 10.4172/0974-276X.S1.071
Warburg effect states the shift in the energy generation metabolism of cancerous cells from oxidative phosphorylation to glycolysis. Nowadays, this statement has regained attention mostly with recent findings about protein acetylation as one of the key post-translational modifications involved in metabolic pathways. Sirtuins, which function as NAD+-dependent deacetylase or ADP ribosyltransferase, are indicated in the regulation of cell survival and longevity in response to the changes in cellular energy state. Alteration in NADH/NAD+ levels is an important driving factor for the activity of sirtuins to deacetylate target proteins and maintain energy homeostasis. Boron is known to be interacting NAD+, and therefore, it may affect the activity of sirtuins and acetylation status of proteins including the metabolic enzymes involved in the oxidative phosphorylation. By targeting sirtuins with boron in order to modify their deacetylatase activity, it is aimed to shift the metabolism of cancer cells from glycolysis to oxidative phosphorylation in order to enhance the efficiency of drugs used in cancer therapy.
Huseyin Cimen has got his BSc in Molecular Biology and Genetics from Middle East Technical University in Turkey and then completed his PhD at the age of 29 years from The Pennsylvania State University with a dissertation titled as ?Regulation of mitochondrial translation and oxidative phosphorylation through reversible acetylation?. He joined Genetics and Bioengineering department at Yeditepe University in Turkey in 2012 and has been founding Yeditepe Proteomics Center as a part of Stem Cell and Gene Therapy Excellence Center, a university service organization.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version